Peptide Therapy Marketing · Thymosin Beta-4

Thymosin Beta-4 Marketing Strategy for Peptide Clinics

Written byTamerlan Musayev·Founder of PeptideLeads

Thymosin Beta-4 is the scientific name recovery patients often search once they have done serious research. Clinics that market under both TB-500 and Thymosin Beta-4 capture the full spectrum of the audience. PeptideLeads was built by founder Tamerlan Musayev to help clinics run coordinated campaigns across related peptide terms. This page describes how we think about Thymosin Beta-4 marketing strategy.

The Market Context

Marketing under the scientific name reaches a slightly different segment than marketing under TB-500. Both exist in the same overall audience but the research-focused buyer searches for Thymosin Beta-4 specifically. We capture both.

Why This Works

A coordinated strategy captures the full addressable audience rather than missing half of it.

How Our Process Works

Audit, coordinated landing pages for both terms, creative, campaigns, leads. Ad spend covered. $50 per qualified lead.

What Makes Us Different

We run both TB-500 and Thymosin Beta-4 as distinct but coordinated campaigns.

$50 Per Lead. No Retainer. We Cover All Ad Spend.

Ready to build a coordinated recovery program? Book a call.

Book a 30-Minute Call Get Matched

Frequently Asked Questions

Should I market under both names?

Yes. Different audiences search each.

How do I price the program?

We share benchmarks.

Is creative included?

Yes.

Is there a contract?

No.

How long until results?

Lead flow within 7 to 14 days.